Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.
作者信息
Tan E M, Shi F-D
机构信息
W M Keck Autoimmune Disease Center, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.
出版信息
Clin Exp Immunol. 2003 Nov;134(2):169-77. doi: 10.1046/j.1365-2249.2003.02259.x.
Abstract
摘要
相似文献
1
Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.
Clin Exp Immunol. 2003 Nov;134(2):169-77. doi: 10.1046/j.1365-2249.2003.02259.x.
2
Antineuroblastoma antibodies in systemic lupus erythematosus.
Isr J Med Sci. 1984 Aug;20(8):720-1.
3
Anti-H1 histone antibodies in systemic lupus erythematosus: epitope localization after immunoblotting of chymotrypsin-digested H1.
Clin Exp Immunol. 1986 Mar;63(3):608-13.
4
[Antibodies against autologous lymphocytes in lupus erythematosus].
Klin Wochenschr. 1972 May 1;50(9):484-6. doi: 10.1007/BF01487608.
5
Profiling the immune responses in patient sera with peptide and cDNA display libraries.
Int J Mol Med. 2000 Aug;6(2):123-8. doi: 10.3892/ijmm.6.2.123.
6
7
Analysis of the clonal origins of autoantibodies against thyroglobulin and DNA in autoimmune thyroiditis and systemic lupus erythematosus.
Clin Exp Immunol. 1986 Sep;65(3):520-33.
8
[Pathophysiology of paraneoplastic neurological syndromes: role of anti-neural antibody and antigen recognition].
Nihon Naika Gakkai Zasshi. 2008 Aug 10;97(8):1809-15. doi: 10.2169/naika.97.1809.
9
Demonstration of anti-asialo GM1 antibody and its neurocytotoxicity in the sera of systemic lupus erythematosus patients.
Asian Pac J Allergy Immunol. 1984 Dec;2(2):195-201.
10
Autoantibodies against protein factors of the nuclear RNA processing apparatus.
Isr J Med Sci. 1992 Feb;28(2):120-3.
引用本文的文献
1
Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers.
Nanomaterials (Basel). 2020 Jun 29;10(7):1274. doi: 10.3390/nano10071274.
2
Autoimmunity and tumor immunology: two facets of a probabilistic immune system.
BMC Syst Biol. 2014 Nov 11;8:120. doi: 10.1186/s12918-014-0120-4.
3
Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens.
Cancer Prev Res (Phila). 2014 May;7(5):545-55. doi: 10.1158/1940-6207.CAPR-13-0416. Epub 2014 Mar 18.
4
Serologic laboratory findings in malignancy.
Rheum Dis Clin North Am. 2011 Nov;37(4):507-25. doi: 10.1016/j.rdc.2011.09.006.
5
Leukocytes in mammary development and cancer.
Cold Spring Harb Perspect Biol. 2011 Mar 1;3(3):a003285. doi: 10.1101/cshperspect.a003285.
6
Encephalitis and epilepsy.
Semin Immunopathol. 2009 Nov;31(4):537-44. doi: 10.1007/s00281-009-0176-1. Epub 2009 Sep 11.
7
Autoantibodies to tumor-associated antigens: reporters from the immune system.
Immunol Rev. 2008 Apr;222:328-40. doi: 10.1111/j.1600-065X.2008.00611.x.
8
Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer.
J Proteome Res. 2008 Apr;7(4):1490-9. doi: 10.1021/pr700804c. Epub 2008 Feb 27.
9
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.
Breast Cancer Res. 2007;9(4):212. doi: 10.1186/bcr1746.
10
The pattern of clinical breast cancer metastasis correlates with a single nucleotide polymorphism in the C1qA component of complement.
Immunogenetics. 2006 Feb;58(1):1-8. doi: 10.1007/s00251-005-0077-y. Epub 2006 Feb 8.
本文引用的文献
1
Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide.
J Clin Invest. 2003 May;111(9):1365-71. doi: 10.1172/JCI17166.
2
Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword.
J Clin Invest. 2003 May;111(9):1280-2. doi: 10.1172/JCI18395.
3
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas.
J Clin Invest. 2003 Apr;111(8):1161-70. doi: 10.1172/JCI17426.
4
Coordinated tumor immunity.
J Clin Invest. 2003 Apr;111(8):1116-8. doi: 10.1172/JCI18359.
5
Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease.
J Clin Invest. 2003 Mar;111(6):907-13. doi: 10.1172/JCI17429.
6
Mutation causing severe myasthenia reveals functional asymmetry of AChR signature cystine loops in agonist binding and gating.
J Clin Invest. 2003 Feb;111(4):497-505. doi: 10.1172/JCI16997.
7
Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):136-43.
8
Prospects for immunotherapy of malignant disease.
Clin Exp Immunol. 2003 Jan;131(1):1-7. doi: 10.1046/j.1365-2249.2003.02055.x.
9
Unravelling the pathogenesis of myasthenia gravis.
Nat Rev Immunol. 2002 Oct;2(10):797-804. doi: 10.1038/nri916.
10
Cancer vaccines: progress reveals new complexities.
J Clin Invest. 2002 Aug;110(3):289-94. doi: 10.1172/JCI16216.
Zotero 插件